| Bioactivity | ERK1/2 inhibitor 12 (compound 76.3) is a ERK1/2 inhibitor which inhibits ERK-mediated phosphorylation of caspase-9 and the p90Rsk-1 kinase. ERK1/2 inhibitor 12 exhibits anti-cancer activity and can be utilized in cancer research[1]. |
| CAS | 350509-85-2 |
| Formula | C13H12N2O4S |
| Molar Mass | 292.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Boston SR, et al. Characterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9. BMC Cancer. 2011 Jan 10;11:7. |
ERK1/2 inhibitor 12
CAS: 350509-85-2 F: C13H12N2O4S W: 292.31
ERK1/2 inhibitor 12 (compound 76.3) is a ERK1/2 inhibitor which inhibits ERK-mediated phosphorylation of caspase-9 and t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.